A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)
A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)
复制标题
DOI：
10.1007/s00125-015-3615-7
复制
发表时间：
2015-07-01
期刊：
影响因子：
8.2
通讯作者：
Dunne, Fidelma
中科院分区：
文献类型：
--
作者：
Benhalima, Katrien;Mathieu, Chantal;Dunne, Fidelma
妊娠期糖尿病（GDM）的筛查和诊断标准在欧洲各地不一致，制定统一的GDM筛查策略是必要的。这一战略将为更多妇女及时接受GDM治疗创造机会。在欧洲就GDM筛查达成共识具有挑战性，因为人口多样化，医疗保健提供系统也各不相同。为了应对这一挑战，欧洲妇产科委员会（EBCOG）任命了一个指导委员会，包括EBCOG和与EASD相关的糖尿病妊娠研究小组（DPSG）的成员，以制定在欧洲使用统一的GDM诊断标准的建议。已经制定了一项提案，目前已由欧洲奥组委理事会批准。目前的建议是在第一次产前接触时使用妊娠期外糖尿病的临界值筛查明显的糖尿病，并特别努力筛查高危人群。当在妊娠24周或更晚进行GDM筛查时，现在建议将75 g OGTT与世卫组织新的GDM诊断标准一起使用。然而，需要更多的研究来评估针对欧洲不同人群的最佳GDM筛查策略。因此，对于是否应该采用普遍的一步、两步或基于风险因素的筛查方法，尚未提出明确的建议。在整个欧洲使用相同的世卫组织GDM诊断标准将是迈向统一的重要一步。
Screening and diagnostic criteria for gestational diabetes (GDM) are inconsistent across Europe, and the development of a uniform GDM screening strategy is necessary. Such a strategy would create opportunities for more women to receive timely treatment for GDM. Developing a consensus on screening for GDM in Europe is challenging, as populations are diverse and healthcare delivery systems also differ. The European Board & College of Obstetrics and Gynaecology (EBCOG) has responded to this challenge by appointing a steering committee, including members of the EBCOG and the Diabetic Pregnancy Study Group (DPSG) associated with the EASD, to develop a proposal for the use of uniform diagnostic criteria for GDM in Europe. A proposal has been developed and has now been approved by the Council of the EBCOG. The current proposal is to screen for overt diabetes at the first prenatal contact using cut-off values for diabetes outside pregnancy, with particular efforts made to screen high-risk groups. When screening for GDM is performed at 24 weeks' gestation or later, the proposal is now to use the 75 g OGTT with the new WHO diagnostic criteria for GDM. However, more research is necessary to evaluate the best GDM screening strategy for different populations in Europe. Therefore, no clear recommendation has been made on whether a universal one-step, two-step or a risk-factor-based screening approach should be used. The use of the same WHO diagnostic GDM criteria across Europe will be an important step towards uniformity.